BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15989536)

  • 1. Developments in the treatment of leishmaniasis and trypanosomiasis.
    Olliaro P; Lazdins J; Guhl F
    Expert Opin Emerg Drugs; 2002 May; 7(1):61-7. PubMed ID: 15989536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of trypanosomiases and leishmaniasis.
    Croft SL; Barrett MP; Urbina JA
    Trends Parasitol; 2005 Nov; 21(11):508-12. PubMed ID: 16150644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetoplastida: new therapeutic strategies.
    Croft SL
    Parasite; 2008 Sep; 15(3):522-7. PubMed ID: 18814734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Situational analysis of leishmaniases research in Kenya.
    Tonui WK
    Afr J Health Sci; 2006; 13(1-2):7-21. PubMed ID: 17348738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine: oral treatment of leishmaniasis.
    Soto J; Soto P
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):177-85. PubMed ID: 16597200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of visceral leishmaniasis: Indian perspective.
    Agrawal S; Rai M; Sundar S
    J Postgrad Med; 2005; 51 Suppl 1():S53-7. PubMed ID: 16519257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
    Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
    Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy in the treatment and control of leishmaniasis.
    Alvar J; Croft S; Olliaro P
    Adv Parasitol; 2006; 61():223-74. PubMed ID: 16735166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of zoonotic leishmaniases and approaches to disease control.
    Gramiccia M; Gradoni L
    Int J Parasitol; 2005 Oct; 35(11-12):1169-80. PubMed ID: 16162348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral miltefosine to treat leishmaniasis].
    Soto J; Soto P
    Biomedica; 2006 Oct; 26 Suppl 1():207-17. PubMed ID: 17361856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral miltefosine for the treatment of Indian visceral leishmaniasis.
    Sundar S; Jha TK; Thakur CP; Bhattacharya SK; Rai M
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S26-33. PubMed ID: 16730038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
    Seifert K; Croft SL
    Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkaloids: future prospective to combat leishmaniasis.
    Mishra BB; Kale RR; Singh RK; Tiwari VK
    Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs and drug resistance in African trypanosomiasis.
    Delespaux V; de Koning HP
    Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of cutaneous leishmaniasis in adults and children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to leishmania: paradox rather than paradigm.
    Tripathi P; Singh V; Naik S
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):229-42. PubMed ID: 17714488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in human African trypanosomiasis.
    Brun R; Balmer O
    Curr Opin Infect Dis; 2006 Oct; 19(5):415-20. PubMed ID: 16940863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.